Page last updated: 2024-09-05

etravirine and bms-790052

etravirine has been researched along with bms-790052 in 2 studies

Compound Research Comparison

Studies
(etravirine)
Trials
(etravirine)
Recent Studies (post-2010)
(etravirine)
Studies
(bms-790052)
Trials
(bms-790052)
Recent Studies (post-2010) (bms-790052)
57290321759120722

Protein Interaction Comparison

ProteinTaxonomyetravirine (IC50)bms-790052 (IC50)
Cytochrome P450 3A4Homo sapiens (human)7.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Burger, DM; D'Avolio, A; Di Perri, G; Drenth, JP; Grintjes, K; Kanter, CT; Smolders, EJ; van Crevel, R1

Other Studies

2 other study(ies) available for etravirine and bms-790052

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir.
    AIDS (London, England), 2016, 06-01, Volume: 30, Issue:9

    Topics: Anti-HIV Agents; Antiviral Agents; Area Under Curve; Carbamates; Coinfection; Darunavir; Diuretics; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Pyrrolidines; Renal Insufficiency; Ritonavir; Treatment Outcome; Valine

2016